Evaluation on Immunogenicity and Safety Profile of Trivalent OPV (tOPV Bio Farma)
NCT02093273
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
240
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
BIOLOGICAL:
tOPV pilot batch
BIOLOGICAL:
tOPV commercial batch
Sponsor
PT Bio Farma